Thomas J. Riga

2020

In 2020, Thomas J. Riga earned a total compensation of $2.5M as President and Chief Executive Officer at Spectrum Pharmaceuticals, a 34% decrease compared to previous year.

Compensation breakdown

Bonus$330,000
Option Awards$1,040,426
Salary$550,000
Stock Awards$450,001
Other$152,372
Total$2,522,799

Riga received $1M in option awards, accounting for 41% of the total pay in 2020.

Riga also received $330K in bonus, $550K in salary, $450K in stock awards and $152.4K in other compensation.

Rankings

In 2020, Thomas J. Riga's compensation ranked 4,510th out of 13,090 executives tracked by ExecPay. In other words, Riga earned more than 65.5% of executives.

ClassificationRankingPercentile
All
4,510
out of 13,090
66th
Division
Manufacturing
1,823
out of 5,618
68th
Major group
Chemicals And Allied Products
706
out of 2,251
69th
Industry group
Drugs
605
out of 1,951
69th
Industry
Pharmaceutical Preparations
459
out of 1,456
69th
Source: SEC filing on April 27, 2022.

Riga's colleagues

We found four more compensation records of executives who worked with Thomas J. Riga at Spectrum Pharmaceuticals in 2020.

2020

Joseph Turgeon

Spectrum Pharmaceuticals

Chief Executive Officer

2020

Francois Lebel

Spectrum Pharmaceuticals

Chief Medical Officer

2020

Kurt Gustafson

Spectrum Pharmaceuticals

Chief Financial Officer

2020

Keith McGahan

Spectrum Pharmaceuticals

Chief Legal Officer

News

You may also like